Vytorin

Gavel court room lawsuit judge

Pharma

Gilead, Merck and others slapped with 'pay-for-delay' lawsuits

New lawsuits claim Gilead, Merck and others engaged in unlawful pay-for-delay deals that cost drug buyers hundreds of millions in overpayments.

Noah Higgins-Dunn Sep 24, 2021 12:05pm

strattera

Lilly's ADHD med Strattera faces generic stampede

May 31, 2017 9:42am

Merck

Merck's Vytorin set for massive sales slide as generics hit

Apr 28, 2017 11:50am

Merck building

Merck’s Frazier gets his first salary boost as CEO

Apr 11, 2017 10:34am